Lempo Therapeutics

Gene Editing for Treatment of Chronic Disease

Active Pre-Funding Startup Binyamina-Giv'at Ada Founded 2017-12

Website ↗ LinkedIn

Lempo Therapeutics is a preclinical biotech company that uses gene editing to modify the immune system for attenuating severe chronic diseases. The companys novel, patented treatment uses an ex vivo stem cell gene-editing technique to minimize the collateral damage caused by immune system activity, thereby significantly mitigating disease progression. Lempo…